What we heard: Agile regulations for advanced therapeutic products and clinical trials

Description

The Health and Biosciences Sector Regulatory Review Roadmap outlined a number of regulatory modernization commitments. These included plans to modernize the regulations for clinical trials and advanced therapeutic products (ATPs).

Resources

Name Format Description Link
What we heard: Agile regulations for advanced therapeutic products and clinical trials HTML https://www.canada.ca/en/health-canada/corporate/about-health-canada/activities-responsibilities/strategies-initiatives/health-products-food-regulatory-modernization/what-we-heard-therapeutic-products-clinical-trials.html
What we heard: Agile regulations for advanced therapeutic products and clinical trials HTML https://www.canada.ca/fr/sante-canada/organisation/a-propos-sante-canada/activites-responsabilites/strategies-initiatives/modernisation-reglementation-aliments-produits-sante/nous-avons-entendu-produits-therapeutiques-essais-cliniques.html

Tags

Topics

Categories